Avoro Capital Advisors LLC Diversified Active

Location: New York, NY

CIK: 0001633313 · Show all filings

Period: Q4 2015 (← Previous) (Next →)

Filing Date: Feb 12, 2016

Total Value: $290M (100.0% shares, 0.0% debt)

Holdings (29)

— MIRATI THERAPEUTICS INC. 13.7%

Value $39.76M Shares 1,258,055 Est. Cost $31.92 Unrealized —

FOLD AMICUS THERAPEUTICS INC 11.7%

Value $34.1M Shares 3,515,611 Est. Cost $7.88 Unrealized +14.4%

— LION BIOTECHNOLOGIES INC 8.5%

Value $24.61M Shares 3,187,607 Est. Cost $10.88 Unrealized —

— LA JOLLA PHARMACEUTICAL CO. 7.3%

Value $21.17M Shares 784,199 Est. Cost $21.78 Unrealized —

SRPT SAREPTA THERAPEUTICS -INC 6.7%

Value $19.41M Shares 503,007 Est. Cost $33.83 Unrealized -4.2%

— PERNIX THERAPEUTICS HOLDINGS 5.2%

Value $15.18M Shares 5,144,916 Est. Cost $4.51 Unrealized —

— DERMIRA INC 4.2%

Value $12.29M Shares 354,950 Est. Cost $23.34 Unrealized —

— TELIGENT INC. 4.2%

Value $12.22M Shares 1,373,294 Est. Cost $8.90 Unrealized —

VNDA VANDA PHARMACEUTICALS INC 4.0%

Value $11.74M Shares 1,260,809 Est. Cost $11.25 Unrealized -11.3%

SRNE SORRENTO THERAPEUTICS INC 3.4%

Value $9.987M Shares 1,146,579 Est. Cost $8.90 Unrealized -5.2%

— AGENUS - INC 3.4%

Value $9.984M Shares 2,199,137 Est. Cost $4.29 Unrealized —

— ONCOTHYREON INC 3.1%

Value $9.144M Shares 4,119,072 Est. Cost $2.20 Unrealized —

— NEURODERM LTD. 3.1%

Value $8.866M Shares 520,022 Est. Cost $18.88 Unrealized —

— NANTKWEST- INC 3.0%

Value $8.828M Shares 599,287 Est. Cost $10.02 Unrealized —

— AEGERION PHARMACEUTICALS INC 2.6%

Value $7.405M Shares 733,125 Est. Cost $13.60 Unrealized —

NBIX NEUROCRINE BIOSCIENCES INC 2.5%

Value $7.184M Shares 127,000 Est. Cost $50.83 Unrealized 0.0%

— AXOVANT SCIENCES LTD. 1.9%

Value $5.536M Shares 307,070 Est. Cost $19.16 Unrealized —

VCYT VERACYTE INC 1.8%

Value $5.338M Shares 741,353 Est. Cost $9.84 Unrealized -31.6%

— EGALET CORPORATION. 1.6%

Value $4.767M Shares 432,606 Est. Cost $13.18 Unrealized —

— INNOCOLL AG 1.4%

Value $4.164M Shares 501,722 Est. Cost $10.71 Unrealized —

— FORTRESS BIOTECH INC. 1.3%

Value $3.733M Shares 1,337,869 Est. Cost $3.14 Unrealized —

— TRILLIUM THERAPEUTICS INC 1.1%

Value $3.199M Shares 253,697 Est. Cost $15.72 Unrealized —

VCEL VERICEL CORP. 1.0%

Value $2.929M Shares 1,135,120 Est. Cost $2.88 Unrealized -22.3%

— TONIX PHARMACEUTICALS HLDG 0.9%

Value $2.61M Shares 340,300 Est. Cost $6.32 Unrealized —

— ACCELERATE DIAGNOSTICS, INC. 0.8%

Value $2.426M Shares 112,885 Est. Cost $21.49 Unrealized —

— ALLIQUA BIOMEDICAL INC 0.6%

Value $1.796M Shares 839,100 Est. Cost $5.15 Unrealized —

CLLS CELLECTIS - ADR 0.4%

Value $1.086M Shares 35,000 Est. Cost $33.40 Unrealized —

SRPT SAREPTA THERAPEUTICS -INC 0.2%

Value $626K Shares 47,300 Est. Cost $33.83 Unrealized -4.2%

— CATALYST BIOSCIENCES INC. 0.1%

Value $224K Shares 71,500 Est. Cost $4.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MIRATI THERAPEUTICS INC.	1,258,055	$39.76M	13.7%	$31.92	—	Common	60468T105
FOLD	AMICUS THERAPEUTICS INC	3,515,611	$34.1M	11.7%	$7.88	+14.4%	Common	03152W109
—	LION BIOTECHNOLOGIES INC	3,187,607	$24.61M	8.5%	$10.88	—	Common	53619R102
—	LA JOLLA PHARMACEUTICAL CO.	784,199	$21.17M	7.3%	$21.78	—	Common	503459604
SRPT	SAREPTA THERAPEUTICS -INC	503,007	$19.41M	6.7%	$33.83	-4.2%	Common	803607100
—	PERNIX THERAPEUTICS HOLDINGS	5,144,916	$15.18M	5.2%	$4.51	—	Common	71426V108
—	DERMIRA INC	354,950	$12.29M	4.2%	$23.34	—	Common	24983L104
—	TELIGENT INC.	1,373,294	$12.22M	4.2%	$8.90	—	Common	87960W104
VNDA	VANDA PHARMACEUTICALS INC	1,260,809	$11.74M	4.0%	$11.25	-11.3%	Common	921659108
SRNE	SORRENTO THERAPEUTICS INC	1,146,579	$9.987M	3.4%	$8.90	-5.2%	Common	83587F202
—	AGENUS - INC	2,199,137	$9.984M	3.4%	$4.29	—	Common	00847G705
—	ONCOTHYREON INC	4,119,072	$9.144M	3.1%	$2.20	—	Common	682324108
—	NEURODERM LTD.	520,022	$8.866M	3.1%	$18.88	—	Common	M74231107
—	NANTKWEST- INC	599,287	$8.828M	3.0%	$10.02	—	Common	63016Q102
—	AEGERION PHARMACEUTICALS INC	733,125	$7.405M	2.6%	$13.60	—	Common	00767E102
NBIX	NEUROCRINE BIOSCIENCES INC	127,000	$7.184M	2.5%	$50.83	0.0%	Common	64125C109
—	AXOVANT SCIENCES LTD.	307,070	$5.536M	1.9%	$19.16	—	Common	G0750W104
VCYT	VERACYTE INC	741,353	$5.338M	1.8%	$9.84	-31.6%	Common	92337F107
—	EGALET CORPORATION.	432,606	$4.767M	1.6%	$13.18	—	Common	28226B104
—	INNOCOLL AG	501,722	$4.164M	1.4%	$10.71	—	Sponsored ADR	45780Q103
—	FORTRESS BIOTECH INC.	1,337,869	$3.733M	1.3%	$3.14	—	Common	34960Q109
—	TRILLIUM THERAPEUTICS INC	253,697	$3.199M	1.1%	$15.72	—	Common	89620X506
VCEL	VERICEL CORP.	1,135,120	$2.929M	1.0%	$2.88	-22.3%	Common	92346J108
—	TONIX PHARMACEUTICALS HLDG	340,300	$2.61M	0.9%	$6.32	—	Common	890260201
—	ACCELERATE DIAGNOSTICS, INC.	112,885	$2.426M	0.8%	$21.49	—	Common	00430H102
—	ALLIQUA BIOMEDICAL INC	839,100	$1.796M	0.6%	$5.15	—	Common	019621200
CLLS	CELLECTIS - ADR	35,000	$1.086M	0.4%	$33.40	—	Sponsored ADS	15117K103
SRPT	SAREPTA THERAPEUTICS -INC	47,300	$626K	0.2%	$33.83	-4.2%	Call	803607100
—	CATALYST BIOSCIENCES INC.	71,500	$224K	0.1%	$4.66	—	Common	14888D109